Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Jefferies London Healthcare Conference (Virtual) Transcript

Nov 18, 2021 / 08:00AM GMT
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Well, welcome to another great session here at the 2021 Jefferies Global London Virtual and In-person Health Care Conference. I am very honored to have with us here on our virtual fireside chat the CEO of Moderna, Stephane Bancel. Thank you. I appreciate your time here today. Certainly, a very busy and, I don't know, a bit chaotic time period mostly because there are so many things going on all over the world.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

I would love to just take a step back, Stephane. And maybe just pause and reflect on sort of where you think we are here in the pandemic and the distribution of COVID vaccines for 2021, and how Moderna is evolving into the end of the year -- you just gave guidance, and how that evolves into 2022? This was some, a bit of, I guess, investor debate about what the guidance sort of tells. But I would love to give you an opportunity to sort of talk about that in 2021 and going to 2022. That

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot